Infection 'Alarm' Yields Clues To Immune System Behavior
Main Category: Immune System / VaccinesAlso Included In: Allergy; Arthritis / Rheumatology; Lupus
Article Date: 05 Mar 2006 - 0:00 PDT
| Patient / Public: | ![]() |
4 (4 votes) |
| Healthcare Prof: | ![]() |
4.67 (3 votes) |
| Article Opinions: | 1 posts |
Drawing on lab experiments and computer studies, Johns Hopkins researchers have learned how a common protein delivers its warning message to cells when an infectious agent invades the body. The findings are important because this biological intruder alarm causes the body's immune system to leap into action to fight the infection. Learning more about how this process works, the researchers said, could lead to better treatments for diseases that occur when the immune system overreacts or pays too little attention to the infection alarm.
Collaborating with colleagues at the University of California, San Diego, the Johns Hopkins researchers have used their discoveries to develop a new computer model that could help produce medications for immune system-related ailments including septic shock, cancer, lupus and rheumatoid arthritis.
Their findings, which focused on how a large protein molecule called tumor necrosis factor, or TNF, triggers an immune response, were reported in the February issue of the Journal of Biological Chemistry.
"We were surprised by how sensitive cells were to small amounts and brief exposures to TNF," said Andre Levchenko, a Johns Hopkins assistant professor of biomedical engineering and senior author of the paper. "Our analysis may help drug companies solve problems with the regulation of immune response levels, and do it in a smart way."
In particular, Levchenko's team looked at the innate immune response, a localized reaction which normally stops an infection threat confined to a small part of the body, such as in the case of a pricked finger. (This is in contrast to a systemic response that triggers an immune reaction throughout the body, causing a fever. If the immune system responds too aggressively in such cases, the result may be a dangerous condition called septic shock.)
The innate immune response begins when white blood cells detect a bacterial intruder or toxin in the body. They produce TNF to carry a message about this health threat to neighboring blood vessel cells, asking them to join in the fight. To send this message, a TNF molecule latches onto the surface of a neighboring cell and accesses a biological information highway called the NF-kappaB pathway. Via a series of chemical reactions that act like signals traveling over a telephone wire, TNF's message moves along this pathway from the cell's surface to its nucleus.
At the end of this pathway, NF-kappaB molecules are released to carry the alarm into the nucleus, the cell's control center. Inside the nucleus, the NF-kappaB molecules switch on genes that produce infection-fighting proteins. These proteins launch several strategies to fight the microscopic invaders, such as sending more white blood cells to engulf the bacteria or toxins. The proteins also set off a response known as inflammation, characterized by redness, swelling and pain.
In their journal article, Levchenko and his colleagues reported several important new discoveries about this cellular signaling system. "You could think of the TNF molecule, which sounds the alarm, as a very weak radio transmitter. It moves very slowly as it carries its warning message to neighboring cells, so it is unable to send that message over long distances," Levchenko said. "However, we discovered that the cellular pathways that pick up this signal act like extremely sensitive radio receivers. They can pick up the alarm message from exposure to even a very small amount of TNF. This turns out to be a very smart strategy on the part of the cells."
He explained that a pricked finger usually generates a very localized fight against infection, involving only nearby cells. If TNF's signal was strong enough to set off an immune response involving the entire body, the result could be a high fever and septic shock. "We've developed a better understanding of why the fight against a local infection stays local," said Raymond Cheong, a graduate student in Levchenko's lab and lead author of the journal article.
The researchers also found that as TNF's warning message travels from the surface of a cell to its nucleus, it receives critical help from a molecule called Inhibitor of KappaB Kinase, or IKK. "IKK filters and interprets the warning message," said Cheong, who is an M.D.-Ph.D. candidate in the Johns Hopkins School of Medicine. "It carefully controls the level of the immune system's response."
That makes IKK a very promising target for new medications designed to boost or suppress the immune system, the researchers said. An overactive immune system, for example, can set off the excessive inflammation associated with rheumatoid arthritis and lupus. In addition, some cancers are more likely to grow where inflammation occurs. These ailments might be helped by a drug that curbs inflammation by reducing the sensitivity of IKK. Still other diseases that are characterized by a weak inflammatory response might be helped by a drug that makes IKK even more sensitive to infection messages.
The researchers believe their computer model of this cellular alarm system, which was refined through lab testing, should be a great help to medication makers. "Models like this are a wonderful tool for experimental drug testing," Levchenko said.
Funding for the research was provided by the National Institutes of Health and the Medical Scientist Training Program at The Johns Hopkins University. Co-authors of the journal article included Adriel Bergmann, a graduate student in the Department of Biomedical Engineering at Johns Hopkins; and Shannon L. Werner, Joshua Regal and Alexander Hoffman, all of the Signaling Systems Laboratory, Department of Chemistry and Biochemistry, University of California, San Diego.
Related links:
Andre Levchenko's Lab Page
bme.jhu.edu/labs/levchenko
Johns Hopkins Department of Biomedical Engineering
bme.jhu.edu
UC San Diego Signaling Systems Laboratory
signalingsystems.ucsd.edu
Johns Hopkins University
901 S. Bond St., Ste 540
Baltimore, MD 21231
United States
jhu.edu:80/~news_info/news
Visit our immune system / vaccines section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/38870.php>
APA
http://www.medicalnewstoday.com/releases/38870.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Lupus - The Infection Connection
posted by Remmel W. Henry Jr. D.D.S. on 23 Apr 2006 at 2:55 pmThis latest article implicating an infectious agent is not new in connecting causes of systemic lupus. My daughter is very sick with this horrible disease. Local so-called experts are poor, at best, in dealing with this disease.
Long ago, infections were indicated as causative factors, and The Road Back Foundation was formed. One of the early findings was that antibiotics on an alternate day schedule help to PREVENT these infectious agents, or some of them from producing even worse antibody activity and increased formation of antibodies.
Why has the medical community been so angry in it's response all too often to this significant factor. I think my daughter's case, and several millios cases of lupus are mistreated by overlooking the relevance of antibiotics in the reduction at least of severe life-threatening events. There are just too many anecdotal pro-antibiotic claims that many, many lupus patients DO improve and maintain an at least somewhat better standard of life, even though the basic cures are not in sight.
I see it as very bad medicine to ignore the use of antibiotic therapy as practiced by a few knowledgable physicians, who are convinced of antibiotic value in addition to the toxic regimens currently being used with disastrous outcomes long term.
The failure of the medical community to recognize antibiotics as a preventive useful tool in the treatment of severe cases, when the evidence is very clear to me, makes me very angry at the local doctors who adamantly refuse to follow the Road Back Protocol. They are NOT curing my daughter!!
What is their objection based on? They are not helping her adequately as it is. I want the local big shot hospital to LISTEN UP to me and use the antibiotic protocol. It has been used in far off places from TEXAS for years, and many patients swear by it's use.
But doctors play GOD, and prefer to use the TOXIC meds such as are now standard. I resent the attitude of the medical profession in this regard, and the indifference to my daughter's likely death within the next 10 years. What is wrong with physicians? Infectious organisms produce all kinds of maladies in various complex ways. Why am I being rejected and reduced to an angry father with no respect for my 39 years researching this disease myself?? I would like a decent response from somebody who CARES! Thank you, Remmel Henry
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




